{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:07:01Z","timestamp":1788138421978,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Microbiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.resmic.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T07:11:51Z","timestamp":1528355511000},"page":"522-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["High precision microfluidic microencapsulation of bacteriophages for enteric delivery"],"prefix":"10.1016","volume":"169","author":[{"given":"Gurinder K.","family":"Vinner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9153-5761","authenticated-orcid":false,"given":"Danish J.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmic.2018.05.011_bib1","series-title":"Antimicrobial Resistance\u202f: a Global View from the 2013 world healthcare-associated infections forum","first-page":"1","author":"Huttner","year":"2013"},{"key":"10.1016\/j.resmic.2018.05.011_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1111","article-title":"The prospect for phage therapy in western medicine","volume":"2","author":"Merril","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.resmic.2018.05.011_bib3","series-title":"Regulation (EC) No 1831\/2003 of the European parliament and of the council of 22 September 2003 on Additives for Use in Animal Nutrition","author":"The European Parliament and The Council of the European Union","year":"2003"},{"key":"10.1016\/j.resmic.2018.05.011_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drup.2011.02.003","article-title":"Critical shortage of new antibiotics in development against multidrug-resistant bacteria \u2014 time to react is now","volume":"14","author":"Freire-moran","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.resmic.2018.05.011_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics \u2014 a pipeline portfolio review","volume":"16","author":"Czaplewski","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib6","first-page":"5","article-title":"Bacteriophages show promise as antimicrobial agents","volume":"36","author":"Alisky","year":"1998","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.resmic.2018.05.011_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.resmic.2018.05.011_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nyas.12468","article-title":"Finding alternatives to antibiotics","volume":"1323","author":"Allen","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.resmic.2018.05.011_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/fpd.2008.0242","article-title":"Kinetics of phage-mediated biocontrol of bacteria","volume":"6","author":"Abedon","year":"2009","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/imr.12565","article-title":"A\u00a0bacteriophages journey through the human body","volume":"279","author":"Barr","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.resmic.2018.05.011_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0966-842X(97)01054-8","article-title":"Bacteriophage therapy and prophylaxis\u202f: rediscovery and renewed assessment of potential","volume":"5","author":"Barrow","year":"1997","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib12","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/1462-2920.13284","article-title":"Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition","volume":"18","author":"Galtier","year":"2016","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrmicro2053","article-title":"Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea","volume":"7","author":"Viswanathan","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.resmic.2018.05.011_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States \u2014 major pathogens","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/318457","article-title":"Nontyphoidal salmonellosis","volume":"32","author":"Hohmann","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AEM.00785-09","article-title":"Phage therapy to reduce preprocessing Salmonella infections in market-weight swine","volume":"76","author":"Wall","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.resmic.2018.05.011_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aad6791","article-title":"Phage therapy redux \u2014 what is to be done?","volume":"350","author":"Young","year":"2015","journal-title":"Science (80-)"},{"key":"10.1016\/j.resmic.2018.05.011_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2009.03.009","article-title":"T4 phages against Escherichia coli diarrhea: potential and problems","volume":"388","author":"Denou","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.resmic.2018.05.011_bib22","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3382\/ps\/pew260","article-title":"Temporal distribution of encapsulated bacteriophages during passage through the chick gastrointestinal tract","volume":"95","author":"Ma","year":"2016","journal-title":"Poultry Sci"},{"key":"10.1016\/j.resmic.2018.05.011_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tifs.2015.07.001","article-title":"Bacteriophage encapsulation\u202f: trends and potential applications a","volume":"45","author":"Choinska-Pulit","year":"2015","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.resmic.2018.05.011_bib24","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AEM.00246-08","article-title":"Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery","volume":"74","author":"Ma","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.foodres.2012.12.037","article-title":"Whey protein improves survival and release characteristics of bacteriophage Felix O1 encapsulated in alginate microspheres","volume":"52","author":"Tang","year":"2013","journal-title":"Food Res Int"},{"key":"10.1016\/j.resmic.2018.05.011_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/ijfs.12736","article-title":"Application of chitosan-alginate microspheres for the sustained release of bacteriophage in simulated gastrointestinal conditions","volume":"50","author":"Kim","year":"2015","journal-title":"Int J Food Sci Technol"},{"key":"10.1016\/j.resmic.2018.05.011_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.foodhyd.2010.11.017","article-title":"Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage","volume":"26","author":"Ma","year":"2012","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.resmic.2018.05.011_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.lwt.2015.08.071","article-title":"Milk-alginate microspheres: protection and delivery of Enterococcus faecalis HZNU P2","volume":"65","author":"Shi","year":"2016","journal-title":"LWT \u2013 Food Sci Technol"},{"key":"10.1016\/j.resmic.2018.05.011_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2008.12.001","article-title":"A\u00a0freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres","volume":"72","author":"Puapermpoonsiri","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.resmic.2018.05.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186239","article-title":"Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release","volume":"12","author":"Vinner","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resmic.2018.05.011_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijfoodmicro.2006.04.047","article-title":"Evaluation of the natural virucidal activity of teas for use in the phage amplification assay","volume":"111","author":"de Siqueira","year":"2006","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.00635-06","article-title":"Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice","volume":"51","author":"Watanabe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.05.011_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1089\/fpd.2013.1600","article-title":"Isolation, characterization and application of bacteriophages for Salmonella spp. biocontrol in pigs","volume":"11","author":"Albino","year":"2014","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/fpd.2011.0905","article-title":"Direct feeding of microencapsulated bacteriophages to reduce salmonella colonization in pigs","volume":"8","author":"Saez","year":"2011","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.resmic.2018.05.011_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","article-title":"Gut instincts: explorations in intestinal physiology and drug delivery","volume":"364","author":"McConnell","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.resmic.2018.05.011_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review","volume":"114","author":"George","year":"2006","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.resmic.2018.05.011_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.lwt.2015.12.039","article-title":"Carrier systems for bacteriophages to supplement food systems\u202f: encapsulation and controlled release to modulate the human gut microbiota","volume":"68","author":"Samtlebe","year":"2016","journal-title":"LWT \u2013 Food Sci Technol"},{"key":"10.1016\/j.resmic.2018.05.011_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.lwt.2014.08.012","article-title":"Preparation and characterization of dry powder bacteriophage K for intestinal delivery through oral administration","volume":"60","author":"Tang","year":"2015","journal-title":"LWT \u2013 Food Sci Technol"},{"key":"10.1016\/j.resmic.2018.05.011_bib39","doi-asserted-by":"crossref","first-page":"41441","DOI":"10.1038\/srep41441","article-title":"Microencapsulation with alginate\/CaCO3: a strategy for improved phage therapy","volume":"7","author":"Colom","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resmic.2018.05.011_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mabi.201200109","article-title":"Novel biopolymer matrices for microencapsulation of Phages\u202f: enhanced protection against acidity and protease activity","volume":"12","author":"Dini","year":"2012","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.resmic.2018.05.011_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejbt.2017.11.006","article-title":"Encapsulation of specific Salmonella Enteritidis phage f3\u03b1SE on alginate-spheres as a method for protection and dosification","volume":"31","author":"Soto","year":"2018","journal-title":"Electron J Biotechnol"},{"key":"10.1016\/j.resmic.2018.05.011_bib42","first-page":"1111","article-title":"The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages","volume":"133","author":"Smith","year":"1987","journal-title":"J\u00a0Gen Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib43","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.05.011_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.resmic.2018.05.011_bib45","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/IAI.70.11.6251-6262.2002","article-title":"Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice","volume":"70","author":"Cerveny","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.resmic.2018.05.011_bib46","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/AEM.00049-07","article-title":"Bacteriophage therapy to reduce Salmonella colonization of broiler chickens","volume":"73","author":"Atterbury","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.05.011_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtbi.2017.06.037","article-title":"Modelling the synergistic elimination of bacteria by phage and the innate immune system","volume":"429","author":"Leung","year":"2017","journal-title":"J Theor Biol"},{"key":"10.1016\/j.resmic.2018.05.011_bib48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage combinations significantly reduce Clostridium difficile growth in\u00a0vitro and proliferation in\u00a0vivo","volume":"60","author":"Nale","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.05.011_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CDLI.5.3.294-298.1998","article-title":"Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves","volume":"5","author":"Barrow","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.resmic.2018.05.011_bib50","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/AAC.48.7.2558-2569.2004","article-title":"In\u00a0vitro and in\u00a0vivo bacteriolytic activities of Escherichia coli Phages\u202f: implications for phage therapy","volume":"48","author":"Chibani-chennoufi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.05.011_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-014-0039-z","article-title":"Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol","volume":"13","author":"Abdulamir","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.resmic.2018.05.011_bib52","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1038\/ncomms14187","article-title":"A\u00a0cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models","volume":"8","author":"Yen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.resmic.2018.05.011_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000253","article-title":"Quantitative models of in\u00a0vitro bacteriophage-host dynamics and their application to phage therapy","volume":"5","author":"Cairns","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.resmic.2018.05.011_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jtbi.2000.2198","article-title":"Understanding bacteriophage therapy as a density-dependent kinetic process","volume":"208","author":"Payne","year":"2001","journal-title":"J\u00a0Theor Biol"},{"key":"10.1016\/j.resmic.2018.05.011_bib55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1263\/jbb.100.280","article-title":"Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice","volume":"100","author":"Tanji","year":"2005","journal-title":"J\u00a0Biosci Bioeng"},{"key":"10.1016\/j.resmic.2018.05.011_bib56","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/jps.22174","article-title":"Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility","volume":"99","author":"Alhnan","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.resmic.2018.05.011_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2010.06.013","article-title":"Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis","volume":"76","author":"Kietzmann","year":"2010","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Research in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250818300858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250818300858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T21:20:32Z","timestamp":1717276832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923250818300858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0923250818300858"],"URL":"https:\/\/doi.org\/10.1016\/j.resmic.2018.05.011","relation":{},"ISSN":["0923-2508"],"issn-type":[{"value":"0923-2508","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High precision microfluidic microencapsulation of bacteriophages for enteric delivery","name":"articletitle","label":"Article Title"},{"value":"Research in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmic.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}]}}